Polymorphisms in folate-metabolizing enzymes and response to 5-fluorouracil among patients with stage II or III rectal cancer (INT-0144; SWOG 9304)
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Polymorphisms in folate-metabolizing enzymes and response to 5-fluorouracil among patients with stage II or III rectal cancer (INT-0144; SWOG 9304)
Authors
Keywords
-
Journal
CANCER
Volume 120, Issue 21, Pages 3329-3337
Publisher
Wiley
Online
2014-07-16
DOI
10.1002/cncr.28830
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic significance of thymidylate synthase polymorphisms in rectal cancer patients treated with neoadjuvant chemoradiotherapy
- (2012) V. Arrazubi et al. Colorectal Disease
- Methylenetetrahydrofolate reductase genetic polymorphisms and toxicity to 5-FU-based chemoradiation in rectal cancer
- (2011) F Thomas et al. BRITISH JOURNAL OF CANCER
- 5-fluorouracil pharmacogenomics: still rocking after all these years?
- (2011) Mario Scartozzi et al. PHARMACOGENOMICS
- Thymidylate Synthase Gene Polymorphism Affects the Response to Preoperative 5-Fluorouracil Chemoradiation Therapy in Patients With Rectal Cancer
- (2010) Hyuk Hur et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Thymidylate synthase germline polymorphisms in rectal cancer patients treated with neoadjuvant chemoradiotherapy based on 5-fluorouracil
- (2010) David Páez et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Prediction of irinotecan and 5-fluorouracil toxicity and response in patients with advanced colorectal cancer
- (2010) B Glimelius et al. PHARMACOGENOMICS JOURNAL
- Tumor response is predicted by patient genetic profile in rectal cancer patients treated with neo-adjuvant chemo-radiotherapy
- (2010) E Cecchin et al. PHARMACOGENOMICS JOURNAL
- MTHFR polymorphisms and 5-FU-based adjuvant chemotherapy in colorectal cancer
- (2009) S. Afzal et al. ANNALS OF ONCOLOGY
- Molecular markers of response and toxicity to FOLFOX chemotherapy in metastatic colorectal cancer
- (2009) W Chua et al. BRITISH JOURNAL OF CANCER
- Predictors of survival and toxicity in patients on adjuvant therapy with 5-fluorouracil for colorectal cancer
- (2009) M Gusella et al. BRITISH JOURNAL OF CANCER
- Methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms and FOLFOX response in colorectal cancer patients
- (2009) Marie-Christine Etienne-Grimaldi et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Association of Molecular Markers With Toxicity Outcomes in a Randomized Trial of Chemotherapy for Advanced Colorectal Cancer: The FOCUS Trial
- (2009) Michael S. Braun et al. JOURNAL OF CLINICAL ONCOLOGY
- An insertion/deletion polymorphism of the dihydrofolate reductase (DHFR) gene is associated with serum and red blood cell folate concentrations in women
- (2008) Anna Stanisławska-Sachadyn et al. HUMAN GENETICS
- A 19-Base Pair Deletion Polymorphism in Dihydrofolate Reductase Is Associated with Increased Unmetabolized Folic Acid in Plasma and Decreased Red Blood Cell Folate
- (2008) Renee D. Kalmbach et al. JOURNAL OF NUTRITION
- Thymidylate synthase haplotype is associated with tumor recurrence in stage II and stage III colon cancer
- (2008) Georg Lurje et al. Pharmacogenetics and Genomics
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now